Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Exposure to rabies during pregnancy

Catherine Windrim, Allison J. McGeer and Kellie E. Murphy
CMAJ October 29, 2018 190 (43) E1281-E1283; DOI: https://doi.org/10.1503/cmaj.180727
Catherine Windrim
Obstetrics and Gynaecology (Windrim), National Maternity Hospital, Dublin, Ireland; Department of Microbiology (McGeer), Mount Sinai Hospital, University of Toronto; Department of Obstetrics and Gynaecology (Murphy), Mount Sinai Hospital, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison J. McGeer
Obstetrics and Gynaecology (Windrim), National Maternity Hospital, Dublin, Ireland; Department of Microbiology (McGeer), Mount Sinai Hospital, University of Toronto; Department of Obstetrics and Gynaecology (Murphy), Mount Sinai Hospital, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kellie E. Murphy
Obstetrics and Gynaecology (Windrim), National Maternity Hospital, Dublin, Ireland; Department of Microbiology (McGeer), Mount Sinai Hospital, University of Toronto; Department of Obstetrics and Gynaecology (Murphy), Mount Sinai Hospital, University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading
KEY POINTS
  • Bats remain the most common source of human rabies exposure in Canada.

  • Postexposure prophylaxis is used in situations that involve direct contact with a bat (i.e., when there has been physical contact between human and bat), and a bite, scratch or exposure to saliva through a mucous membrane or wound cannot be ruled out.

  • Pregnancy is not a contraindication for postexposure prophylaxis.

A 44-year-old pregnant woman (gravida 6 para 3) received counselling after being bitten by a bat during her 26th week of pregnancy. The patient reported that a bat had flown down and bitten her hand in broad daylight. The patient’s partner hit the bat, which fell to the ground. The patient thoroughly washed the wound and sought immediate medical attention. The bat’s carcass was kept for testing.

The patient was immediately started on a postexposure prophylaxis schedule, including both rabies vaccine and rabies immunoglobulin. The bat was sent to the Canadian Food Inspection Agency Centre of Excellence for Rabies in Ottawa, Ontario, where a direct fluorescent antibody test confirmed that the bat had been rabid. The patient completed treatment — four doses of rabies vaccine and one dose of rabies immunoglobulin.

At 28 weeks’ gestation, the patient presented with premature prelabour rupture of membranes. She received routine care (betamethasone for fetal lung maturation and prophylactic erythromycin). At 30 weeks, the patient went into preterm labour and underwent cesarean delivery. She gave birth to a healthy boy, weighing 1474 g (50th percentile), with no further complications.

Discussion

Rabies is a uniformly fatal viral infection characterized by acute progressive encephalitis.1 Its incubation period varies from weeks to months depending on several variables, including the strain of the virus involved. Infected animals can infect others before clinical signs are present. However, only four cases of rabies in humans were reported in Canada between 1991 and 2016, owing to multidisciplinary efforts to minimize human exposure to rabies and to prompt, effective use of postexposure prophylaxis.2,3

Although exposure to rabies during pregnancy is uncommon, animal bites do occur, and pregnant women should receive postexposure prophylaxis. Treatment during pregnancy is the same as it is for nonpregnant women. Canadian health care providers must report all potential human exposures to rabies to local public health departments. Because the risk of rabies varies with different mammals and in different regions, providers are encouraged to seek public health guidance when rabies exposure is suspected.2

In North America, the most common source of human rabies exposure is bats.4 Of Canada’s 18 species of bat, two live indoors: the little brown bat and the big brown bat. Most bats found in homes are big brown bats, because they are better adapted to living inside year-round. Little brown bats are nearing extinction owing to an epidemic fungal infection called white nose syndrome. Along with the tricoloured bat and northern myotis, they are protected under Canadian law as endangered species because of their declining populations.5

Other animals can be infected by rabies. In Canada in 2017, of the submitted animal specimens tested, 239 gave positive results for rabies. These specimens included raccoons, skunks, bats, arctic and red foxes, cattle, dogs and cats.6 A substantial contributor to bats’ perceived danger as a vector of rabies is their very fine teeth: a person may not see or feel a bite mark and thus may not be prompted to seek treatment. A 2009 study involving 14 453 people in Quebec found that about 1 in 1000 people experience bat exposures in bedrooms without recognized bites each year. However, researchers calculated that the incidence of human rabies resulting from such exposures is 1 per 2.7 billion human-years.7 Thus, although bat exposures in the bedroom are common, the risk of rabies infection is remote without direct contact.

Current recommendations for bat exposure counsel “intervention for situations when there is direct contact with a bat (i.e., there has been physical contact between human and bat) and a bite, scratch, or saliva exposure into a mucous membrane or wound cannot be ruled out.”4 Examples of situations in which one might not be able to rule out direct contact include exposures in young children, older adults or people with disabilities.

If bats are found in a home, one should contact an appropriate pest control service, which will use the “exclusion method” to stop bats from re-entry: blocking potential points of entry with one-way doors (letting bats leave but not return) and sealing large structural cracks. These methods do not harm the bats, but are effective at preventing further nesting.5

Most bat species are protected in Canada and should only be captured for testing if direct contact has been confirmed.4 Attempting to capture a bat puts a person at risk of exposure and should be left to trained wildlife professionals.

People who think that they may have been bitten by, or made direct contact with, a bat or other animal and cannot rule out a bite should immediately wash and thoroughly flush the wound with soap and water, then seek medical attention. We counselled our patient to begin a postexposure vaccination schedule. Because pregnancy is not a contraindication for postexposure prophylaxis7 and treatment can be discontinued if there is proof that the animal is not infected, there is no reason to delay using inactivated vaccine and immunoglobulin to prevent lethal infection. In this case, testing confirmed that the bat was rabid, and a full course of postexposure prophylaxis was given (Boxes 1 and 2).4

Box 1:

Postexposure management to prevent rabies after a bite or contact with animal saliva4

View this table:
  • View inline
  • View popup
  • Download powerpoint
Box 2:

Postexposure prophylaxis for rabies4

View this table:
  • View inline
  • View popup
  • Download powerpoint

Apprehension about using rabies vaccines and immunoglobulin in pregnancy is common owing to a lack of large cohort studies categorically establishing their safety. Live virus vaccines (e.g., smallpox, varicella, measles) are contraindicated in pregnancy because of the potential risk of congenital abnormalities that can from fetal infection. Rabies vaccines, however, are killed whole-virus vaccines and can be safely administered during pregnancy. No fetal adverse events have been reported with non-live virus vaccines. Rabies immunoglobulin is a blood product, and carries no more potential risk of viral infection than any other blood product. Immunoglobulin, when indicated, can be safely given during pregnancy.

Two cohort studies that documented the results of rabies postexposure prophylaxis during pregnancy found no negative outcomes. Sudarshan and colleagues tracked 14 cases in which postexposure prophylaxis was administered to pregnant women until their children were one year old, and found healthy outcomes for all exposed mothers and babies.8 Toovey and colleagues documented 251 pregnancies during which postexposure prophylaxis was given, and found no cases of congenital malformation or spontaneous abortion.9 In our patient’s case, her pregnancy was complicated by prelabour preterm rupture of membranes and preterm birth. We do not believe that her exposure to rabies was associated with these complications, and we were not able to identify any other reports of these complications after exposure to rabies or receipt of postexposure prophylaxis.

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

  • The authors have obtained patient consent.

  • Contributors: All three authors (Windrim, McGeer, Murphy) contributed to the conception, writing and revision of this case report. Catherine Windrim initially drove this project, as a summer medical student project. Allison McGeer reviewed the manuscript and served as a content expert. All three authors reviewed and approved the final version of this paper and agreed to act as guarantors of the results.

References

  1. ↵
    Rabies [fact sheet]. Geneva: World Health Organization; [updated 2017]. Available: www.who.int/mediacentre/factsheets/fs099/en/ (accessed 2018 Feb. 11).
  2. ↵
    Management of potential rabies exposure guideline, 2018. Toronto: Ontario Ministry of Health and Long-Term Care; 2013. Available: www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/protocols_guidelines/Management_of_Potential_Rabies_Exposures_2018_en.pdf (accessed 2018 Oct. 11).
  3. ↵
    Reported cases by age group in Canada, grouped by sex — notifiable diseases online. Ottawa: Public Health Agency of Canada; 2016. Available: http://diseases.canada.ca/notifiable/charts?c=abs (accessed 2018 Mar. 15).
  4. ↵
    Active vaccines. In: Canadian Immunization Guide: part 4. Ottawa: Public Health Agency of Canada; 2012. Available: www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-18-rabies-vaccine.html# (accessed 2018 July 25).
  5. ↵
    Got bats? 7 steps for managing bats in buildings: a guide for pest management professionals [pamphlet]. Community Bat Programs of BC; 2015. Available: www.cwhc-rcsf.ca/docs/7_Steps_for_Managing_Bats_in_Buildings.pdf (accessed 2018 Oct. 11).
  6. ↵
    Rabies in Canada. Ottawa: Canadian Food Inspection Agency; [modified 2018]. Available: www.inspection.gc.ca/animals/terrestrial-animals/diseases/reportable/rabies/rabies-in-canada/eng/1519159995664/1519159996478 (accessed 2018 Oct. 11).
  7. ↵
    1. De Serres G,
    2. Skowronski DM,
    3. Mimault P,
    4. et al
    . Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies postexposure prophylaxis. Clin Infect Dis 2009;48:1493–9.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Sudarshan MK,
    2. Ananda Giri MS
    . Assessing the safety of post-exposure rabies immunization in pregnancy. Hum Vaccin 2007;3:87–9.
    OpenUrl
  9. ↵
    1. Toovey S
    . Preventing rabies with the Verorab vaccine: 1985–2005. Travel Med Infect Dis 2007;5:327–48.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 190 (43)
CMAJ
Vol. 190, Issue 43
29 Oct 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Exposure to rabies during pregnancy
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Exposure to rabies during pregnancy
Catherine Windrim, Allison J. McGeer, Kellie E. Murphy
CMAJ Oct 2018, 190 (43) E1281-E1283; DOI: 10.1503/cmaj.180727

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Exposure to rabies during pregnancy
Catherine Windrim, Allison J. McGeer, Kellie E. Murphy
CMAJ Oct 2018, 190 (43) E1281-E1283; DOI: 10.1503/cmaj.180727
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Discussion
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Modern Rhesus (Rh) typing in transfusion and pregnancy
  • Remdesivir for patients with COVID-19
  • Syphilis presenting with moth-eaten alopecia
Show more Practice

Similar Articles

Collections

  • Sections
    • Cases
  • Topics
    • Public health
    • Vaccination
    • Maternal-fetal medicine
    • Infectious diseases

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire